← Leaderboards
Genevieve Giny Fouda Amou Ou
Duke University
$19,482,405
Attributed
$24,314,720
Total exposure
14
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.4M · FY2015–25$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,314,720 · 14
By mechanism
R01$17,052,897 · 5
P01$5,230,232 · 4
R25$703,847 · 1
TL1$694,865 · 1
R21$474,674 · 2
R03$158,205 · 1
Top collaborators
- Matthew Scott Kelly5 shared
- Sallie R. Permar5 shared
- Joel H Collier4 shared
- Yazmin Paulina Carrasco2 shared
- Joy Deanna Howell2 shared
- Holly Janes1 shared
Most similar at Duke University
Same institution · by research overlap
- Michael Barry Kastan$65,974,699
- Herbert Kim Lyerly$48,598,090
- Richard Di Giulio$22,812,396
- Nelson J. Chao$27,968,804
- John H Sampson$43,413,436
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodAntibodiesVaccinesVaccinationVirusAdultAntibody ResponseInfantResponseInfectionChildImmuneB-LymphocytesImmunizationPreventEpitopesAntigensDesignNeutralizing AntibodyLifeHiv VaccinePediatric Human Immunodeficiency VirusImmune SystemPlasma
Grant awards (38)
Leveraging novel pediatric SHIVs to identify biomarkers of prophylactic efficacy of bnAb against breast milk HIV transmission$4,686,370
R01 · FY2025 · AI · contact PI
Modulation of the immune response to B cell lineage-based immunization by other immune interventions administered in infancy$944,979
P01 · FY2025 · AI · contact PI
Early life B cell responses and inflammation following SARS-CoV-2 infection$838,453
R01 · FY2025 · AI · contact PI
J. NRSA Training Core$694,865
TL1 · FY2025 · TR · contact PI
Defining and modeling HIV-1-specific antibody function in HIV-1-exposed Infants passively Infused with broadly neutralizing antibodies in the IMPAACT P1112 trial.$273,424
R21 · FY2025 · HD · contact PI
Early life B cell responses and inflammation following SARS-CoV-2 infection$852,895
R01 · FY2024 · AI · contact PI
Advancing Success and Persistence in Research Education (ASPiRE)$346,564
R25 · FY2024 · GM
Neutralizing and non-neutralizing antibody effector functions in HIV infected children$749,233
R01 · FY2023 · AI · contact PI
Early life B cell responses and inflammation following SARS-CoV-2 infection$706,463
R01 · FY2023 · AI · contact PI
Advancing Success and Persistence in Research Education (ASPiRE)$357,283
R25 · FY2023 · GM
Early life B cell responses and inflammation following SARS-CoV-2 infection$762,710
R01 · FY2022 · AI · contact PI
Supramolecular pediatric HIV vaccine design$761,359
R01 · FY2022 · AI
Neutralizing and non-neutralizing antibody effector functions in HIV infected children$694,601
R01 · FY2022 · AI · contact PI
Project 2: RNA vaccination in early life to induce potent and broad HIV Env-specific antibody responses$343,969
P01 · FY2022 · AI · contact PI
Early life B cell responses and inflammation following SARS-CoV-2 infection$854,272
R01 · FY2021 · AI · contact PI
Supramolecular pediatric HIV vaccine design$767,636
R01 · FY2021 · AI · contact PI
Project 2: RNA vaccination in early life to induce potent and broad HIV Env-specific antibody responses$714,185
P01 · FY2021 · AI · contact PI
Neutralizing and non-neutralizing antibody effector functions in HIV infected children$707,803
R01 · FY2021 · AI · contact PI
Project 2: Impact of immune-based intervention on viral rebound in orally SHIV infected infant monkeys$240,430
P01 · FY2021 · AI · contact PI
Supramolecular pediatric HIV vaccine design$777,485
R01 · FY2020 · AI · contact PI
Neutralizing and non-neutralizing antibody effector functions in HIV infected children$730,146
R01 · FY2020 · AI · contact PI
Project 2: RNA vaccination in early life to induce potent and broad HIV Env-specific antibody responses$546,751
P01 · FY2020 · AI · contact PI
Functional profile to HIV vaccine elicited antibodies in infants$401,073
R01 · FY2020 · AI · contact PI
Project 2: Impact of immune-based intervention on viral rebound in orally SHIV infected infant monkeys$363,121
P01 · FY2020 · AI · contact PI
Project 2: Impact of immune-based intervention on viral rebound in orally SHIV infected infant monkeys$261,702
P01 · FY2020 · AI · contact PI
Molecular signatures of broad neutralization in HIV infected children$201,250
R21 · FY2020 · HD · contact PI
Supramolecular pediatric HIV vaccine design$793,206
R01 · FY2019 · AI · contact PI
Neutralizing and non-neutralizing antibody effector functions in HIV infected children$748,130
R01 · FY2019 · AI · contact PI
B Cell Core$407,075
P01 · FY2019 · AI · contact PI
Functional profile to HIV vaccine elicited antibodies in infants$400,591
R01 · FY2019 · AI · contact PI
Project 2: Impact of immune-based intervention on viral rebound in orally SHIV infected infant monkeys$384,964
P01 · FY2019 · AI · contact PI
Functional profile to HIV vaccine elicited antibodies in infants$400,494
R01 · FY2018 · AI · contact PI
Project 2: Impact of immune-based intervention on viral rebound in orally SHIV infected infant monkeys$343,774
P01 · FY2018 · AI · contact PI
B Cell Core$265,942
P01 · FY2018 · AI · contact PI
Functional profile to HIV vaccine elicited antibodies in infants$419,977
R01 · FY2017 · AI · contact PI
Project 2: Impact of immune-based intervention on viral rebound in orally SHIV infected infant monkeys$413,340
P01 · FY2017 · AI · contact PI
Infant immune correlates of perinatal mother to child transmission of HIV$78,705
R03 · FY2016 · HD · contact PI
Infant immune correlates of perinatal mother to child transmission of HIV$79,500
R03 · FY2015 · HD · contact PI